EuroMEEting - Genetic Alliance UK
EuroMEEting - Genetic Alliance UK
EuroMEEting - Genetic Alliance UK
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
4<br />
EUROMEETING 2011 THEME LEADERS<br />
Christelle Anquez-Traxler<br />
Regulatory and Scientific Affairs<br />
Manager, AESGP, Belgium<br />
Robert Hemmings<br />
Statistics Unit Manager, MHRA, <strong>UK</strong><br />
Michael Pfleiderer<br />
Head of Section, Viral Vaccines,<br />
Paul-Erhlich-Institut (PEI), Germany<br />
Timothy Buxton<br />
Head of Sector, ICT Development,<br />
European Medicines Agency, EU<br />
Michael Hotze<br />
Director, Head of Clinical Research,<br />
Institut Straumann AG, Switzerland<br />
Ineke Rijnhout<br />
Consultant, Kenko International,<br />
The Netherlands<br />
Vincenzo Cannizzaro<br />
Regulatory Affairs Specialist, Spain<br />
Wills Hughes-Wilson<br />
Senior Director, Health Policy Europe,<br />
Genzyme, Belgium<br />
Jean-Louis Robert<br />
Head, Department of Medicines Control<br />
Laboratory, National Health Laboratory,<br />
Luxembourg<br />
Chris Chamberlain<br />
Medical Director, Personalised Medicines,<br />
AstraZeneca Pharmaceuticals LP, <strong>UK</strong><br />
David Iberson-Hurst<br />
Vice President, Technical Strategy,<br />
CDISC, <strong>UK</strong><br />
Tomas Salmonson<br />
Vice Chairman, CHMP, Director Scientific<br />
and Regulatory Strategies, MPA, Sweden<br />
Olivier Chassany<br />
Medical Head, Clinical Research &<br />
Development Department, Assistance<br />
Publique - Hôpitaux de Paris, France<br />
Angelika Joos<br />
Director, Regulatory Policy, Europe,<br />
Merck Sharp & Dohme (Europe) Inc.,<br />
Belgium<br />
Urszula Scieszko-Fic<br />
Registration Director, Temapharm Sp.<br />
z.o.o., Poland<br />
Nancy Claude<br />
Director of Drug Safety, IRIS, France<br />
Jürgen Kübler<br />
Global Head, Statistical Safety Sciences,<br />
Novartis Pharma AG, Switzerland<br />
Philippa Smit-Marshall<br />
Vice President Medical and Scientific<br />
Affairs, PharmaNet B.V., The Netherlands<br />
Philippe Close<br />
Chief Safety Officer, Novartis Pharma<br />
AG, Switzerland<br />
Pierre-Yves Lastic<br />
Senior Director, Data Privacy &<br />
Healthcare Interoperability Standards,<br />
sanofi-aventis, France<br />
Per Spindler<br />
Director, Biopeople, University of<br />
Copenhagen, Denmark<br />
Bruno Flamion<br />
Chair Scientific Advice Working Party<br />
(SAWP), CHMP; Professor Clinical<br />
Pharmacology, University of Namur,<br />
Belgium<br />
Georges France<br />
Vice President, Quality Strategy, Global<br />
Quality Operation, Pfizer, <strong>UK</strong><br />
Birka Lehmann<br />
Director and Professor, Head of Licensing<br />
Division 3, BfArM, Germany<br />
Andrew P. Marr<br />
Director, Global eRegulatory<br />
Development, Global Regulatory<br />
Operations, GlaxoSmithKline, <strong>UK</strong><br />
Sabine Straus<br />
Head of Pharmacovigilance, Medicines<br />
Evaluation Board (MEB), The<br />
Netherlands<br />
Thomas Verstraeten<br />
Head Biologicals Clinical Safety &<br />
Pharmacovigilance, GlaxoSmithKline<br />
Biologicals, Belgium<br />
Shayesteh Fuerst-Ladani<br />
Director, SFL Regulatory Affairs and<br />
Scientific Communication, Switzerland<br />
Henrik Kim Nielsen<br />
Corporate Vice President, Novo Nordisk<br />
A/S, Denmark<br />
Christa Wirthumer-Hoche<br />
Deputy Head, AGES PharmMed, Austria<br />
About the DIA EuroMeeting<br />
The Drug Information Association’s Annual EuroMeeting is global in scope, attracting well over 3,000 professionals from over 50 countries. It brings together<br />
professionals from the biopharmaceutical industry, contract service organisations, academic research centres, regulatory agencies and health ministries as well as<br />
delegates from patient organisations. This convergence affords participants the opportunity to network with professional colleagues from around the world.<br />
The DIA is a professional association of approximately 18,000 members worldwide who are involved in the discovery, development, regulation, surveillance or<br />
marketing of pharmaceuticals or related products. The DIA is committed to the broad dissemination of information on the development of new medicines or<br />
generics, biosimilars, medical devices and combination products with continuously improved professional practice as the goal. The DIA is an independent non-profit<br />
organisation. The voluntary efforts of DIA members and speakers allow the DIA to organise conferences, workshops and training courses and provide publications<br />
at a reasonable, competitive cost.<br />
DIA Europe's Customer Services Team will be pleased to assist you with your registration. Please call us on +41 61 225 51 51 from Monday to Friday between<br />
08:00 and 17:00 CET.
Change language